ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 92 filers reported holding ALLOVIR INC in Q3 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,915,782 | -35.4% | 2,751,526 | +2.2% | 0.00% | – |
| Q2 2023 | $9,152,545 | -21.9% | 2,691,925 | -9.4% | 0.00% | – |
| Q1 2023 | $11,712,875 | -22.6% | 2,972,811 | +0.7% | 0.00% | – |
| Q4 2022 | $15,138,218 | -34.1% | 2,950,920 | +1.4% | 0.00% | -100.0% |
| Q3 2022 | $22,969,000 | +187.5% | 2,911,200 | +42.1% | 0.00% | – |
| Q2 2022 | $7,988,000 | -55.8% | 2,048,010 | -23.5% | 0.00% | – |
| Q1 2022 | $18,078,000 | -50.0% | 2,678,301 | -4.1% | 0.00% | -100.0% |
| Q4 2021 | $36,148,000 | -48.4% | 2,793,583 | -0.0% | 0.00% | -50.0% |
| Q3 2021 | $70,039,000 | +50.8% | 2,794,854 | +18.8% | 0.00% | +100.0% |
| Q2 2021 | $46,435,000 | -9.2% | 2,352,343 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $51,140,000 | -5.6% | 2,185,463 | +55.1% | 0.00% | -50.0% |
| Q4 2020 | $54,168,000 | +45.3% | 1,409,158 | +3.9% | 0.00% | +100.0% |
| Q3 2020 | $37,280,000 | – | 1,355,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |